He has a secondary appointment with the Department of Biochemistry and Molecular & Cellular Biology. His research focuses on molecular mechanisms of malignant transformation and drug discovery in pediatric sarcomas. Some of the active projects in his laboratory include development of targeted therapies against EWS-FLI1 and CD99 in Ewing’s Sarcoma, ERG in prostate cancer, ezrin in osteosarcoma and Pax3-Foxo1 in rhabdomyosarcoma. He also runs a core facility at Georgetown University that provides surface plasmon resonance technology (Biacore 4000 and Biacore T200) to academic institutions and biopharmaceutical companies. He teaches tumor biology to graduate students and gross anatomy to medical students, for which he has received multiple teaching awards including the Golden Apple and Golden Orchard.